BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

953 related articles for article (PubMed ID: 28797433)

  • 1. Periprocedural Myocardial Injury Depends on Transcatheter Heart Valve Type But Does Not Predict Mortality in Patients After Transcatheter Aortic Valve Replacement.
    Stundl A; Schulte R; Lucht H; Weber M; Sedaghat A; Shamekhi J; Zur B; Grube E; Mellert F; Welz A; Fimmers R; Nickenig G; Werner N; Sinning JM
    JACC Cardiovasc Interv; 2017 Aug; 10(15):1550-1560. PubMed ID: 28797433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Functional Outcomes Associated With Myocardial Injury After Transfemoral and Transapical Transcatheter Aortic Valve Replacement: A Subanalysis From the PARTNER Trial (Placement of Aortic Transcatheter Valves).
    Paradis JM; Maniar HS; Lasala JM; Kodali S; Williams M; Lindman BR; Damiano RJ; Moon MR; Makkar RR; Thourani VH; Babaliaros V; Xu K; Ayele GM; Svensson L; Leon MB; Zajarias A
    JACC Cardiovasc Interv; 2015 Sep; 8(11):1468-1479. PubMed ID: 26404200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of prosthesis-iteration evolution and sizing practice on the incidence of prosthesis-patient mismatch after transcatheter aortic valve replacement.
    Abdelghani M; Allali A; Kaur J; Hemetsberger R; Mehilli J; Neumann FJ; Frerker C; Kurz T; El-Mawardy M; Richardt G; Abdel-Wahab M
    Catheter Cardiovasc Interv; 2019 Apr; 93(5):971-979. PubMed ID: 30467966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
    Jatene T; Castro-Filho A; Meneguz-Moreno RA; Siqueira DA; Abizaid AAC; Ramos AIO; Arrais M; Le Bihan DCS; Barretto RBM; Moreira AC; Sousa AGMR; Eduardo Sousa J
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):139-146. PubMed ID: 28029207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes for the Commercial Use of Self-Expanding Prostheses in Transcatheter Aortic Valve Replacement: A Report From the STS/ACC TVT Registry.
    Sorajja P; Kodali S; Reardon MJ; Szeto WY; Chetcuti SJ; Hermiller J; Chenoweth S; Adams DH; Popma JJ
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2090-2098. PubMed ID: 29050627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and effect of myocardial injury after transcatheter aortic valve replacement.
    Barbash IM; Dvir D; Ben-Dor I; Badr S; Okubagzi P; Torguson R; Corso PJ; Xue Z; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2013 May; 111(9):1337-43. PubMed ID: 23415511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary Access After TAVR.
    Ochiai T; Chakravarty T; Yoon SH; Kaewkes D; Flint N; Patel V; Mahani S; Tiwana R; Sekhon N; Nakamura M; Cheng W; Makkar R
    JACC Cardiovasc Interv; 2020 Mar; 13(6):693-705. PubMed ID: 32192689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and hemodynamic results after direct transcatheter aortic valve replacement versus pre-implantation balloon aortic valvuloplasty: A case-matched analysis.
    Ferrera C; Nombela-Franco L; Garcia E; Jimenez-Quevedo P; Biagioni C; Gonzalo N; Nuñez-Gil I; Viana-Tejedor A; Salinas P; Alberto de Agustin J; Almeria C; Islas F; Perez de Isla L; Fernandez-Perez C; Escaned J; Fernández-Ortiz A; Macaya C
    Catheter Cardiovasc Interv; 2017 Nov; 90(5):809-816. PubMed ID: 27515377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Redo Transcatheter Aortic Valve Replacement for the Treatment of Postprocedural and Late Occurrence of Paravalvular Regurgitation and Transcatheter Valve Failure.
    Barbanti M; Webb JG; Tamburino C; Van Mieghem NM; Makkar RR; Piazza N; Latib A; Sinning JM; Won-Keun K; Bleiziffer S; Bedogni F; Kapadia S; Tchetche D; Rodés-Cabau J; Fiorina C; Nombela-Franco L; De Marco F; de Jaegere PP; Chakravarty T; Vaquerizo B; Colombo A; Svensson L; Lange R; Nickenig G; Möllmann H; Walther T; Della Rosa F; Elhmidi Y; Dvir D; Brambilla N; Immè S; Sgroi C; Gulino S; Todaro D; Pilato G; Petronio AS; Tamburino C
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves: Results From the CHOICE Randomized Clinical Trial.
    Abdel-Wahab M; Landt M; Neumann FJ; Massberg S; Frerker C; Kurz T; Kaur J; Toelg R; Sachse S; Jochheim D; Schäfer U; El-Mawardy M; Robinson DR; Richardt G;
    JACC Cardiovasc Interv; 2020 May; 13(9):1071-1082. PubMed ID: 32305398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial.
    Elmariah S; Fearon WF; Inglessis I; Vlahakes GJ; Lindman BR; Alu MC; Crowley A; Kodali S; Leon MB; Svensson L; Pibarot P; Hahn RT; Thourani VH; Palacios IF; Miller DC; Douglas PS; Passeri JJ;
    JACC Cardiovasc Interv; 2017 Dec; 10(23):2414-2422. PubMed ID: 29217004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct Comparison of Feasibility and Safety of Transfemoral Versus Transaortic Versus Transapical Transcatheter Aortic Valve Replacement.
    Arai T; Romano M; Lefèvre T; Hovasse T; Farge A; Le Houerou D; Hayashida K; Watanabe Y; Garot P; Benamer H; Unterseeh T; Bouvier E; Morice MC; Chevalier B
    JACC Cardiovasc Interv; 2016 Nov; 9(22):2320-2325. PubMed ID: 27884356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Year Outcomes With the Evolut R Self-Expanding Transcatheter Aortic Valve: From the International FORWARD Study.
    Manoharan G; Van Mieghem NM; Windecker S; Bosmans J; Bleiziffer S; Modine T; Linke A; Scholtz W; Chevalier B; Gooley R; Zeng C; Oh JK; Grube E
    JACC Cardiovasc Interv; 2018 Nov; 11(22):2326-2334. PubMed ID: 30466832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications After Self-expanding Transcatheter or Surgical Aortic Valve Replacement.
    Conte JV; Hermiller J; Resar JR; Deeb GM; Gleason TG; Adams DH; Popma JJ; Yakubov SJ; Watson D; Guo J; Zorn GL; Reardon MJ
    Semin Thorac Cardiovasc Surg; 2017 Autumn; 29(3):321-330. PubMed ID: 29195573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial.
    Søndergaard L; Steinbrüchel DA; Ihlemann N; Nissen H; Kjeldsen BJ; Petursson P; Ngo AT; Olsen NT; Chang Y; Franzen OW; Engstrøm T; Clemmensen P; Olsen PS; Thyregod HG
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27296202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early versus newer generation transcatheter heart valves for transcatheter aortic valve implantation: Echocardiographic and hemodynamic evaluation of an all-comers study cohort using the dimensionless aortic regurgitation index (AR-index).
    Stundl A; Lucht H; Shamekhi J; Weber M; Sedaghat A; Mellert F; Grube E; Nickenig G; Werner N; Sinning JM
    PLoS One; 2019; 14(5):e0217544. PubMed ID: 31150455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery: A Study of Echocardiographic Change and Risk Prediction.
    Little SH; Oh JK; Gillam L; Sengupta PP; Orsinelli DA; Cavalcante JL; Chang JD; Adams DH; Zorn GL; Pollak AW; Abdelmoneim SS; Reardon MJ; Qiao H; Popma JJ
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27313280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial.
    Baron SJ; Thourani VH; Kodali S; Arnold SV; Wang K; Magnuson EA; Pichard AD; Babaliaros V; George I; Miller DC; Tuzcu EM; Greason K; Herrmann HC; Smith CR; Leon MB; Cohen DJ;
    JACC Cardiovasc Interv; 2018 Jun; 11(12):1188-1198. PubMed ID: 29860075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and impact of myocardial injury after transcatheter aortic valve replacement: a multicenter registry.
    Ribeiro HB; Nombela-Franco L; Muñoz-García AJ; Lemos PA; Amat-Santos I; Serra V; de Brito FS; Abizaid A; Sarmento-Leite R; Puri R; Cheema AN; Ruel M; Nietlispach F; Maisano F; Moris C; Del Valle R; Urena M; Abdul Jawad Altisent O; Del Trigo M; Campelo-Parada F; Jimenez Quevedo P; Alonso-Briales JH; Gutiérrez H; García Del Blanco B; Perin MA; Siqueira D; Bernardi G; Dumont É; Côté M; Pibarot P; Rodés-Cabau J
    J Am Coll Cardiol; 2015 Nov; 66(19):2075-2088. PubMed ID: 26541917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
    Montone RA; Testa L; Fraccaro C; Montorfano M; Castriota F; Nerla R; Angelillis M; Tusa M; Giannini F; Garatti A; Tarantini G; Petronio AS; Brambilla N; Bedogni F
    Catheter Cardiovasc Interv; 2017 Dec; 90(7):1206-1211. PubMed ID: 28145039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.